Hermann P T Ammon

Summary

Country: Germany

Publications

  1. ncbi The phosphatase inhibitor okadaic acid blocks KCl-depolarization-induced rise of cytosolic calcium of rat insulinoma cells (RINm5F)
    H P Ammon
    Department of Pharmacology, University of Tubingen, Germany
    Naunyn Schmiedebergs Arch Pharmacol 354:95-101. 1996
  2. ncbi K-ATP channel independent effects of pinacidil on ATP production in isolated cardiomyocyte or pancreatic beta-cell mitochondria
    Nicolas Lembert
    Department of Pharmacology, University of Tubingen, Tubingen, Germany
    Biochem Pharmacol 65:1835-41. 2003
  3. ncbi Modulation of the immune system by Boswellia serrata extracts and boswellic acids
    H P T Ammon
    Department of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany
    Phytomedicine 17:862-7. 2010
  4. ncbi [Cinnamon in type 2 diabetics]
    Hermann P T Ammon
    Pharmakologie für Naturwissenschaftler, Pharmazeutisches Institut, Universitat Tubingen, Tubingen
    Med Monatsschr Pharm 31:179-83. 2008
  5. ncbi Boswellic acids in chronic inflammatory diseases
    H P T Ammon
    Dept of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany
    Planta Med 72:1100-16. 2006
  6. ncbi [Boswellic acids (the active agent in incense) for the treatment of chronic inflammatory diseases]
    Hermann P Ammon
    , Auf der Morgenstelle 8,
    Med Monatsschr Pharm 26:309-15. 2003
  7. ncbi [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]
    H P T Ammon
    Lehrstuhl Pharmakologie für Naturwissenschaftler, Pharmazeutisches Institut der Universität Tübingen, Deutschland
    Wien Med Wochenschr 152:373-8. 2002
  8. ncbi In vitro test of new biomaterials for the development of a bioartificial pancreas
    N Lembert
    Institute of Pharmaceutical Sciences, University of Tubingen, Germany
    Ann N Y Acad Sci 944:271-6. 2001
  9. ncbi Macroencapsulation of rat islets without alteration of insulin secretion kinetics
    N Lembert
    Department of Pharmacology, University of Tubingen, Germany
    Exp Clin Endocrinol Diabetes 109:116-9. 2001
  10. ncbi Methyl pyruvate initiates membrane depolarization and insulin release by metabolic factors other than ATP
    N Lembert
    Department of Pharmacology, Institute of Pharmaceutical Sciences, University of Tubingen, Auf der Morgenstelle 8, D 72076 Tubingen, Germany
    Biochem J 354:345-50. 2001

Collaborators

Detail Information

Publications17

  1. ncbi The phosphatase inhibitor okadaic acid blocks KCl-depolarization-induced rise of cytosolic calcium of rat insulinoma cells (RINm5F)
    H P Ammon
    Department of Pharmacology, University of Tubingen, Germany
    Naunyn Schmiedebergs Arch Pharmacol 354:95-101. 1996
    ..The data also suggest that in RINm5F cells protein phosphatases PP-1/PP-2A are related to the function of voltage-dependent calcium channels...
  2. ncbi K-ATP channel independent effects of pinacidil on ATP production in isolated cardiomyocyte or pancreatic beta-cell mitochondria
    Nicolas Lembert
    Department of Pharmacology, University of Tubingen, Tubingen, Germany
    Biochem Pharmacol 65:1835-41. 2003
    ..In beta-cells without a metabolically inhibited succinate dehydrogenase, there is no stimulation by PIN and tissue protection by PIN is not to be expected...
  3. ncbi Modulation of the immune system by Boswellia serrata extracts and boswellic acids
    H P T Ammon
    Department of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany
    Phytomedicine 17:862-7. 2010
    ....
  4. ncbi [Cinnamon in type 2 diabetics]
    Hermann P T Ammon
    Pharmakologie für Naturwissenschaftler, Pharmazeutisches Institut, Universitat Tubingen, Tubingen
    Med Monatsschr Pharm 31:179-83. 2008
    ..In contrary the medical site in this case claims cinnamon as a drug because of its pharmacological effects on glucose tolerance, insulin resistance, insulin release and blood-sugar. In the meantime this is a case of jurisdiction...
  5. ncbi Boswellic acids in chronic inflammatory diseases
    H P T Ammon
    Dept of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany
    Planta Med 72:1100-16. 2006
    ..Side effects are not severe when compared to modern drugs used for the treatment of these diseases...
  6. ncbi [Boswellic acids (the active agent in incense) for the treatment of chronic inflammatory diseases]
    Hermann P Ammon
    , Auf der Morgenstelle 8,
    Med Monatsschr Pharm 26:309-15. 2003
  7. ncbi [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]
    H P T Ammon
    Lehrstuhl Pharmakologie für Naturwissenschaftler, Pharmazeutisches Institut der Universität Tübingen, Deutschland
    Wien Med Wochenschr 152:373-8. 2002
    ..In clinical trials promising results were observed in patients with rheumatoid arthritis, chronic colitis, ulcerative colitis, Crohn's disease, bronchial asthma und peritumoral brains edemas...
  8. ncbi In vitro test of new biomaterials for the development of a bioartificial pancreas
    N Lembert
    Institute of Pharmaceutical Sciences, University of Tubingen, Germany
    Ann N Y Acad Sci 944:271-6. 2001
    ..In conclusion, in vitro membrane screening identified highly substituted hydroxy-methylated PSU as the material of choice for islet encapsulation in a bioartificial pancreas...
  9. ncbi Macroencapsulation of rat islets without alteration of insulin secretion kinetics
    N Lembert
    Department of Pharmacology, University of Tubingen, Germany
    Exp Clin Endocrinol Diabetes 109:116-9. 2001
    ..In conclusion, highly substituted hydroxy methylated polysulphone allows a rapid and efficient insulin release after macroencapsulation and is suited for the further development of a bioartificial pancreas...
  10. ncbi Methyl pyruvate initiates membrane depolarization and insulin release by metabolic factors other than ATP
    N Lembert
    Department of Pharmacology, Institute of Pharmaceutical Sciences, University of Tubingen, Auf der Morgenstelle 8, D 72076 Tubingen, Germany
    Biochem J 354:345-50. 2001
    ..Instead MP may exert a direct extramitochondrial effect, or it may stimulate beta-cell mitochondria to produce coupling factors different from ATP to initiate insulin release...
  11. ncbi Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL
    H Safayhi
    Department of Pharmacology, University of Tuebingen, Germany
    Planta Med 66:110-3. 2000
    ..The in vitro data underline the major importance of drug standardization when Boswellia resin containing preparations are used for the treatment of diseases...
  12. ncbi Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I
    R F Hoernlein
    Institute of Pharmaceutical Sciences, Department of Pharmacology, Tuebingen
    J Pharmacol Exp Ther 288:613-9. 1999
    ..The data suggest that induction of apoptosis in HL-60 and CCRF-CEM by AKBA may be due to inhibition of topoisomerase I in these cells...
  13. ncbi Distribution and stimulation by gastrin-releasing peptide of protein kinase C subfamilies in insulin-secreting cells
    A Bihlmayer
    Department of Pharmacology, Institute of Pharmaceutical Sciences, Eberhard-Karls University, , Germany
    Neuroendocrinology 73:352-7. 2001
    ..It is suggested that PKC alpha, beta and/or zeta may play a role in the modulation of insulin secretion by GRP...
  14. ncbi [Ca(2+)](i)- and insulin-stimulating effect of the non-membranepermeable phosphatase-inhibitor microcystin-LR in intact insulin-secreting cells (RINm5F)
    T Leiers
    Department of Pharmacology, Institute of Pharmaceutical Sciences, Eberhard Karls University Tubingen, Germany
    Br J Pharmacol 130:1406-10. 2000
    ..5. From these data we conclude that microcystin-LR could affect Ca(2+)-channels and insulin release by inhibiting an extracellular phosphatase-like activity...
  15. ncbi Distribution of protein phosphatases type 1 and 2A in RINm5F cells
    T Cartus
    Institute of Pharmaceutical Sciences, Department of Pharmacology, University of Tubingen, Germany
    Regul Pept 77:77-81. 1998
    ..The data suggest that in membrane and nuclear fractions of RINmSF cells predominantly PP1 is present, whereas in the cytosol PP1 as well as PP2A can be detected...
  16. ncbi Optimized biosensor for whole blood measurements using a new cellulose based membrane
    S Eisele
    Department of Pharmacology, , Germany
    Biosens Bioelectron 9:119-24. 1994
    ..In addition, the measuring range of the glucose sensor could be extended up to 170 mM glucose by treating the bacterial cellulose membrane with a polyamide...
  17. ncbi Potentiation of forskolin-induced increase of cAMP by diamide and N-ethylmaleimide in rat pancreatic islets
    M I Anazodo
    Pharmazeutisches Institut, Abteilung Pharmakologie, , Germany
    Horm Metab Res 22:61-4. 1990
    ..The potentiation of forskolin-induced cAMP production in intact islet cells by diamide and NEM may be due to inactivation of the thiols related to the Ni-protein...